Suppr超能文献

冠心病患者的糖尿病、胰岛素抵抗和动脉粥样硬化替代标志物。

Diabetes, insulin resistance and atherosclerosis surrogates in patients with coronary atherosclerosis.

机构信息

Department of Cardiology, Heart Center, College of Medicine, Konyang University, Deajeon, Korea.

出版信息

Korean Circ J. 2010 Feb;40(2):62-7. doi: 10.4070/kcj.2010.40.2.62. Epub 2010 Feb 23.

Abstract

BACKGROUND AND OBJECTIVES

Undiagnosed diabetes mellitus (DM) or impaired glucose tolerance (IGT) is not uncommon in patients with coronary atherosclerosis and is known to be associated with abnormal scores for atherosclerosis surrogates. We sought to determine the prevalence of undiagnosed DM or IGT, and the association between insulin resistance (IR) and atherosclerosis surrogates in patients with coronary atherosclerosis.

SUBJECTS AND METHODS

The study population consisted of 187 consecutive patients with angiographically proven coronary atherosclerosis (mean: 61 years old, 94 males). We measured carotid intima-media thickness (IMT) and flow mediated brachial artery dilatation (FMD). We also did oral glucose tolerance tests (OGTT), quantitative insulin-sensitivity check indexes (QUICKI) and homeostasis model assessment-IR (HOMA-IR).

RESULTS

Abnormal OGTT was found in 164 patients (87.7%), even though there were only 63 known cases of DM (33.7%). There were 58 patients (31%) with newly diagnosed IGT and 43 patients (23%) with newly diagnosed DM. There were 71 patients (38%) who had IR (defined as measured HOMA-R >/=3.0). HOMA-IR showed a positive correlation with body mass index (BMI) (r=0.275, p<0.001) and triglycerides (r=0.2, p=0.01), whereas QUICKI had a negative correlation with BMI (r=-0.26, p<0.001), total cholesterol (r=-0.15, p=0.04), triglycerides (r=-0.21, p=0.004) and low-density lipoprotein-cholesterol (LDL-C) (r=-0.17, p=0.02). HOMA-IR and QUICKI were not significantly correlated with IMT or FMD.

CONCLUSION

This study suggests that there is a high incidence of undiagnosed DM and IGT, but atherosclerosis surrogates are not associated with IR in patients with coronary atherosclerosis.

摘要

背景与目的

在患有冠状动脉粥样硬化的患者中,未确诊的糖尿病(DM)或糖耐量受损(IGT)并不少见,已知其与动脉粥样硬化替代物的异常评分有关。我们旨在确定患有冠状动脉粥样硬化的患者中未确诊的 DM 或 IGT 的患病率,以及胰岛素抵抗(IR)与动脉粥样硬化替代物之间的关系。

受试者和方法

研究人群包括 187 例经血管造影证实的冠状动脉粥样硬化患者(平均年龄 61 岁,男性 94 例)。我们测量了颈动脉内膜中层厚度(IMT)和血流介导的肱动脉扩张(FMD)。我们还进行了口服葡萄糖耐量试验(OGTT)、定量胰岛素敏感性检查指数(QUICKI)和稳态模型评估-IR(HOMA-IR)。

结果

164 例患者(87.7%)出现异常 OGTT,尽管仅有 63 例已知 DM 病例(33.7%)。有 58 例(31%)患者被诊断为新的 IGT,43 例(23%)患者被诊断为新的 DM。有 71 例(38%)患者存在 IR(定义为测定的 HOMA-R≥3.0)。HOMA-IR 与体重指数(BMI)呈正相关(r=0.275,p<0.001)和甘油三酯(r=0.2,p=0.01),而 QUICKI 与 BMI 呈负相关(r=-0.26,p<0.001),与总胆固醇(r=-0.15,p=0.04)、甘油三酯(r=-0.21,p=0.004)和低密度脂蛋白胆固醇(LDL-C)(r=-0.17,p=0.02)。HOMA-IR 和 QUICKI 与 IMT 或 FMD 无显著相关性。

结论

本研究表明,在患有冠状动脉粥样硬化的患者中,未确诊的 DM 和 IGT 的发病率较高,但胰岛素抵抗与动脉粥样硬化替代物无关。

相似文献

引用本文的文献

本文引用的文献

7
Endothelial dysfunction: a marker of atherosclerotic risk.内皮功能障碍:动脉粥样硬化风险的标志物。
Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):168-75. doi: 10.1161/01.atv.0000051384.43104.fc.
10
Inflammation and atherosclerosis.炎症与动脉粥样硬化。
Circulation. 2002 Mar 5;105(9):1135-43. doi: 10.1161/hc0902.104353.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验